Chloe Botaine

Chloe Botaine

Biopharmaceutical Research Specialist
Chloe Botaine specializes in biopharmaceutical research and development, offering insights into the latest trends, challenges, and breakthroughs in biopharma. Her content covers topics such as drug discovery, clinical trials, and regulatory affairs. With a focus on advancing science and improving patient care, Chloe’s content contributes to the development of innovative therapies and medicines that address unmet medical needs and improve public health outcomes.
Enhancing Cyber Resilience in Healthcare: Strategies and Challenges
Regulatory & Compliance Enhancing Cyber Resilience in Healthcare: Strategies and Challenges

The healthcare sector is continuously evolving, but along with these advancements come increased vulnerabilities to cyber threats. Cyber resilience has thus become paramount. This article explores the dynamic landscape of cyber resilience in the healthcare industry, the key challenges, and the

FDA Approves Illumina's Pan-Cancer Genomic Profiling Test for Therapy
Imaging & Diagnostics FDA Approves Illumina's Pan-Cancer Genomic Profiling Test for Therapy

The FDA's recent approval of Illumina's TruSight Oncology (TSO) Comprehensive, an in vitro diagnostic (IVD) biomarker test kit, represents a notable milestone in cancer treatment. This approval paves the way for more personalized and precise therapy options for cancer patients. By

Innovations and Market Dynamics in the Computed Tomography Industry
Imaging & Diagnostics Innovations and Market Dynamics in the Computed Tomography Industry

The computed tomography (CT) scanner industry has experienced rapid growth and significant advancements, transforming how healthcare professionals approach diagnosis and treatment planning. This article delves into the key innovations driving the market, industry trends, and the factors shaping its

How Are Drug Distributors Contributing to the Opioid Crisis Settlement?
Regulatory & Compliance How Are Drug Distributors Contributing to the Opioid Crisis Settlement?

The opioid crisis has left an indelible mark on American society, thrusting numerous stakeholders, particularly drug distributors, into the spotlight. The recent $300 million settlement by McKesson, Cardinal, and Cencora represents one of the latest significant efforts to address the multifaceted

Omnicell Introduces Central Med Automation to Transform Pharmacy Care
Infrastructure & Management Omnicell Introduces Central Med Automation to Transform Pharmacy Care

In a major leap towards transforming pharmacy care, Omnicell, Inc. has revealed its Central Med Automation Service in Fort Worth, Texas. This innovative service aims to overhaul traditional medication management systems, leveraging advanced technology to enhance efficiency and reduce errors across

How Will Omnicell's Automation Service Transform Pharmacy Care?
Infrastructure & Management How Will Omnicell's Automation Service Transform Pharmacy Care?

The evolution of Omnicell's automation service marks a significant moment in the healthcare industry. Omnicell, Inc., recognized as a leader in pharmacy services innovation, has launched the Central Med Automation Service in Fort Worth, Texas. This new service aims to revolutionize how health

How Will Wisconsin's Biohealth Tech Hub Transform Cancer Treatment?
Imaging & Diagnostics How Will Wisconsin's Biohealth Tech Hub Transform Cancer Treatment?

Wisconsin is poised to revolutionize cancer treatment and the broader healthcare landscape through the establishment of a biohealth tech hub, supported by a significant $49 million federal investment. This ambitious initiative aims to spur innovations in personalized medicine and biohealth

Can AI and Digital Fax Bridge Healthcare’s Tech Divide?
Digital Health Can AI and Digital Fax Bridge Healthcare’s Tech Divide?

Healthcare's journey toward data interoperability has been punctuated by the rallying cry, "ax the fax." This call to action underscores a widespread belief among many healthcare stakeholders that reliance on fax technology is a significant barrier to seamless information exchange.

Kaiser Permanente Implementing Abridge AI to Streamline Documentation
Digital Health Kaiser Permanente Implementing Abridge AI to Streamline Documentation

Kaiser's Huge Healthcare Partnership Accelerates AI-Powered Medical Note-Taking Kaiser Permanente's recent implementation of Abridge's AI-powered medical note-taking technology across its extensive healthcare network marks a significant milestone in the integration of artificial

Will Roche Divest Flatiron Health to Overcome Ownership Challenges?
Imaging & Diagnostics Will Roche Divest Flatiron Health to Overcome Ownership Challenges?

In a significant development in the intersection of healthcare and technology, Roche is reportedly considering divesting Flatiron Health, a prominent cancer data startup it acquired for $1.9 billion in 2018. The acquisition was initially aimed at harnessing real-world evidence to propel

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later